Luciferase Reporter Cell Line - REH

1. Gene transcription regulation research: REH cell lines provide a powerful tool for gene transcription regulation research by expressing Luciferase reporter genes under the control of specific regulatory elements. The luminescent properties of the Luciferase gene enable researchers to monitor the transcriptional activity of target genes in real time through simple and sensitive bioluminescence assays. Researchers can use these cell lines to explore the effects of various regulatory factors (such as transcription factors, signaling molecules, and drugs) on gene expression, thereby revealing the complex mechanisms of gene regulatory networks. In addition, through high-throughput screening, researchers can identify and verify potential regulatory elements and drug targets.

2. Immune system disease research: REH cells are derived from tissues of patients with acute lymphoblastic leukemia (ALL) and exhibit the characteristics of precursor B cells. They express a variety of key immune-related markers (such as CD3A, CD3B, CD3C, CD4, and CD10), making them an important tool for studying immune system diseases. Through these cell lines, researchers can deeply explore the pathogenesis of leukemia, disorders of the immune system, and related signal transduction pathways. In addition, REH cells can also be used to test the effectiveness and safety of new immunotherapy drugs, providing data support for the treatment of leukemia and other immune diseases.

3. Three-dimensional cell culture: REH cells are very suitable for three-dimensional cell culture models, which can better simulate the in vivo cell environment. Three-dimensional culture not only helps to study cell behavior and interactions, but also provides more realistic drug response data. Three-dimensional culture technology enables researchers to conduct experiments in an environment that is closer to the physiological conditions in vivo, thereby obtaining more physiologically relevant results.